×
About 8,528 results

ALLMedicine™ Alopecia Center

Research & Reviews  2,753 results

Are dissecting cellulitis and hidradenitis suppurativa different diseases?
https://doi.org/10.1016/j.clindermatol.2021.01.002
Clinics in Dermatology; Federico A, Rossi A et. al.

Sep 15th, 2021 - Although dissecting cellulitis (DC) and hidradenitis suppurativa (HS) are classified separately, they share many clinical, dermatoscopic, pathogenetic, and histologic aspects, as well as therapeutic options. The association between DC, HS, and acn...

Evidence for lymphocytic inflammation in nonlesional scalp of folliculitis decalvans: a...
https://doi.org/10.1111/jdv.17649
Journal of the European Academy of Dermatology and Venere... Doche I, Hordinsky MK et. al.

Sep 13th, 2021 - Folliculitis decalvans (FD) is a neutrophilic primary cicatricial alopecia (CA) affecting mostly middle-aged males. Key features include confluent areas of CA, surrounded by polytrichia (tufted hairs), pustules and crusting mainly over the vertex ...

Association between angiotensin-converting enzyme gene insertion deletion polymorphism ...
https://doi.org/10.1111/jocd.14434
Journal of Cosmetic Dermatology; Mustafa AI, Ibrahim SE et. al.

Sep 10th, 2021 - Androgenetic alopecia (AGA) is a prevalent condition with a complex etiopathogenesis. Angiotensin-converting enzyme (ACE) gene located on the chromosome 17q23 contains an insertion (I) and deletion (D) polymorphism in the intron 16. This gene poly...

PPARγ signaling protects hair follicle stem cells from chemotherapy-induced apoptosis a...
https://doi.org/10.1111/bjd.20745
The British Journal of Dermatology; Piccini I, Brunken L et. al.

Sep 9th, 2021 - Permanent chemotherapy-induced alopecia (pCIA), for which preventive interventions remain limited, can manifest with scarring. While the underlying pathomechanisms of pCIA are unclear, depletion of epithelial hair follicle (HF) stem cells (eHFSCs)...

Incidence and comorbidities of pediatric alopecia areata: a retrospective matched cohor...
https://doi.org/10.1016/j.jaad.2021.08.050
Journal of the American Academy of Dermatology; Ali NS, Tollefson MM et. al.

Sep 7th, 2021 - Incidence and comorbidities of pediatric alopecia areata: a retrospective matched cohort study using the Rochester Epidemiology Project.|2021|Ali NS,Tollefson MM,Lohse CM,Torgerson RR,|

see more →

Guidelines  3 results

Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss...
https://doi.org/10.1111/1346-8138.14470
The Journal of Dermatology; Manabe M, Tsuboi R et. al.

Jun 5th, 2018 - Male-pattern hair loss (MPHL, androgenetic alopecia) is a slowly progressive form of alopecia which begins after puberty. In 2010, we published the first Japanese edition of guidelines for the diagnosis and treatment of MPHL. It achieved the origi...

Guidelines for management of androgenetic alopecia based on BASP classification--the As...
https://doi.org/10.1111/jdv.12034
Journal of the European Academy of Dermatology and Venere... Lee WS, Lee HJ et. al.

Nov 28th, 2012 - Androgenetic alopecia (AGA), or pattern hair loss, is a common disorder in both Asian men and women. There are several guidelines for the treatment of AGA which are suitable for Caucasian patients; however, each of these has some limitations. Furt...

British Association of Dermatologists' guidelines for the management of alopecia areata...
https://doi.org/10.1111/j.1365-2133.2012.10955.x
The British Journal of Dermatology; Messenger AG, McKillop J et. al.

Apr 25th, 2012 - British Association of Dermatologists' guidelines for the management of alopecia areata 2012.|2012|Messenger AG,McKillop J,Farrant P,McDonagh AJ,Sladden M,|diagnosis,etiology,therapy,methods,therapeutic use,methods,methods,methods,

see more →

Drugs  259 results see all →

Clinicaltrials.gov  9 results

Sodium Valproate-loaded Nanospanlastics in Patchy Alopecia Areata in Comparison to Topical Steroids
https://clinicaltrials.gov/ct2/show/NCT05017454

Aug 23rd, 2021 - Alpopecia Areata (AA) is the second common cause of non-scarring hair loss, the disease has huge negative impact on patients' quality of life, social and psychological status. The underlying pathogenesis of AA is not fully characterized, Yet the c...

A Phase II Study in Patients With Alopecia Areata
https://clinicaltrials.gov/ct2/show/NCT04346316

Jul 16th, 2021 - The study is placebo-controlled, meaning that some patients entering the study will not receive active study drug but will receive tablets with no active ingredients (a placebo). This is a dose-ranging study, investigating 3 different dosing regim...

Follicular Revival in Treatment-resistant Alopecia Areata: Evaluating Use of Micro-needling
https://clinicaltrials.gov/ct2/show/NCT04338295

Apr 21st, 2021 - This will be a trial evaluating the efficacy of micro-needling via tattoo device in stimulating scalp hair growth in patients with AA refractory to combination JAK inhibitor and oral minoxidil treatment. Ten healthy subjects who are at least eight...

Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia
https://clinicaltrials.gov/ct2/show/NCT01325337

Apr 10th, 2014 - This study will evaluate the safety and efficacy of 3 doses of bimatoprost solution compared with vehicle and over-the-counter (OTC) minoxidil 5% solution in men with androgenic alopecia. All treatments will be provided in a double-blinded fashion...

Microarray Analysis of Scalp Biopsies After Minoxidil Treatment
https://clinicaltrials.gov/ct2/show/NCT01309191

Feb 27th, 2014 - The most common type of hair loss is androgenetic alopecia (AGA), also known as male pattern balding, or hereditary thinning. In AGA, there is a gradual transformation of large terminal hair follicles to miniaturized ones under the influence of ci...

see more →

News  385 results

Dr. Richardson on the FDA Approval of Melphalan Flufenamide in Relapsed/Refractory Multiple Myeloma
https://www.onclive.com/view/dr-richardson-on-the-fda-approval-of-melphalan-flufenamide-in-relapsed-refractory-multiple-myeloma

Aug 17th, 2021 - Paul G. Richardson, MD, clinical program leader and director of clinical research, Jerome Lipper Multiple Myeloma Center, physician, Dana-Farber Cancer Institute, and RJ Corman Professor of Medicine at Harvard Medical School, discusses the FDA app...

Pediatric Alopecia Areata in the US Has Increased Twofold Since 2009, Study Finds
https://www.medscape.com/viewarticle/954901

Jul 16th, 2021 - The prevalence of pediatric alopecia areata (AA) in the United States has increased twofold over the past decade and it disproportionately affects females and Hispanic children, according to results from the largest study to date on the topic. "Al...

FDA Grants Regular Approval to Enfortumab Vedotin, Expands Indication for Locally Advanced or Metastatic Urothelial Cancer
https://www.onclive.com/view/fda-grants-regular-approval-to-enfortumab-vedotin-expands-indication-for-locally-advanced-or-metastatic-urothelial-cancer

Jul 9th, 2021 - The FDA has granted a regular approval to enfortumab vedotin-ejfv (Padcev) and has expanded the agent's indication to include adult patients with locally advanced or metastatic urothelial cancer who are ineligible for cisplatin-containing chemothe...

Datopotamab Deruxtecan Shows Encouraging Preliminary Safety, Efficacy in TNBC
https://www.onclive.com/view/datopotamab-deruxtecan-shows-encouraging-preliminary-safety-efficacy-in-tnbc

May 8th, 2021 - The differentiated TROP2-directed antibody-drug conjugate (ADC) datopotamab deruxtecan (DS-1062a) was found to have promising antitumor activity with a manageable safety profile in heavily pretreated patients with triple-negative breast cancer (TN...

Relapsing Lupus Nephritis and Cutaneous Vasculitis: A Race to Contain B Cells
https://www.medscape.com/viewarticle/949863

Apr 28th, 2021 - This article originally appeared on the Hospital for Special Surgery's website. Case Report A 45-year-old woman with a history of systemic lupus erythematosus (SLE) since 2006 came to the Hospital for Special Surgery in 2014 for continued manageme...

see more →

Patient Education  2 results see all →